War is lead cause behind huge drop in global vaccinations, UN warns

Vaccine misinformation has added to crisis of collapsed healthcare and poor nutrition, Unicef and WHO report

Conflicts have hampered efforts to vaccinate children across the world, health leaders have warned, as new figures showed about 14.5 million children had not received a single immunisation dose.

More than half of the children live in countries where armed conflicts or other humanitarian crises had created fragile and vulnerable situations, according to data from the UN children’s agency, Unicef, and the World Health Organization.

Continue reading...

HPV vaccine after removal of precancerous cells may cut cervical cancer risk

Study finds reduced risk of cervical cancer recurring after HPV vaccination post-surgery, though further research is needed

Giving women the human papillomavirus (HPV) vaccine when precancerous lesions are removed from their cervix may cut the risk of cells recurring and them getting cervical cancer, a study has found.

Cases of cervical cancer in the UK have fallen hugely since school pupils aged 13 and 14 – first girls and later boys – began being offered HPV jabs in 2008 as protection against the disease.

Continue reading...

Women can be protected from cervical cancer – so why aren’t we doing it?

Amid a global shortage of HPV vaccine, more must be done to steer supplies towards those most at risk: girls in poor countries

For too many women, cervical cancer is a death sentence. But it doesn’t have to be. A life-saving preventative vaccine can dramatically cut cases and put the world on track to eliminate this deadly disease.

The UK first began offering a vaccine against HPV – the primary cause of cervical cancer – in 2008. According to a 2018 study by Public Health England, infections of certain cancer-causing types of HPV have since fallen by 86% among 16- to 21-year-old women. A study conducted in Scotland last year found that the vaccine reduced pre-cancerous cervical lesions by up to 90%.

Continue reading...

Mass cervical cancer vaccine rollout could save 62 million lives in next 100 years

Studies project rapidly deploying HPV vaccine in 78 of the world’s poorest countries could help prevent more than 74 million cases

More than 74m cervical cancer cases and 62m deaths could be averted in the next 100 years if 78 of the world’s poorest countries rapidly deploy HPV vaccinations, cervical screening and cancer treatment, two new studies have projected.

The predictive modelling is published on Friday in Lancet by Université Laval, Harvard University and Cancer Council New South Wales working with the World Health Organisation. All three teams independently developed their models based on the biological understanding of cervical cancer, and multiple data sources from multiple countries located in east Asia and Pacific, Europe and central Asia, Latin America and Caribbean, the Middle East and North Africa, South Asia, and sub-Saharan Africa.

Continue reading...